Barry Follweiler
Internal Medicine · New Tripoli, PANPI 1942297502
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 24.4% of the total. Reporting peaked in 2021 at $1,481 and has fallen 97.3% since, to $40 in 2022.
Across 211 payments — averaging $15.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$823
- AstraZeneca$455
- Boehringer Ingelheim$429
- Pfizer$289
- Johnson & Johnson$248
- GSK$212
- plus $912 from 16 others
What the payments were for
- Food & beverage$3,367100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 52 | $823 |
| AstraZeneca | 29 | $455 |
| Boehringer Ingelheim | 21 | $429 |
| Pfizer | 22 | $289 |
| Johnson & Johnson | 15 | $248 |
| GSK | 12 | $212 |
| Lilly USA, LLC | 15 | $210 |
| Merck | 12 | $184 |
| Esperion Therapeutics, Inc. | 13 | $183 |
| Sanofi-aventis U.S. LLC | 5 | $73 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Phadia US Inc. | 1 | $26 |
| Bausch Health US, LLC | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Amgen | 1 | $18 |
| Bayer | 1 | $17 |
| Seqirus USA Inc | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,367 in reported general payments places this provider in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in New Tripoli
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- Ronak BhimaniNorristown$623K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
- Eyob FeyssaPhiladelphia$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.